Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
-0.20 (-0.65%)
Sep 10, 2025, 12:40 PM CST

Sofiva Genomics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
6658638767841,0421,093
Upgrade
Market Cap Growth
-58.25%-1.51%11.72%-24.75%-4.66%-27.16%
Upgrade
Enterprise Value
5957847986849061,004
Upgrade
Last Close Price
30.8039.6040.5335.3745.1146.10
Upgrade
PE Ratio
-46.8175.9818.3318.2931.57
Upgrade
PS Ratio
1.641.901.881.582.052.24
Upgrade
PB Ratio
1.051.341.421.251.671.98
Upgrade
P/TBV Ratio
1.061.361.431.261.691.99
Upgrade
P/FCF Ratio
32.2948.54325.36-14.4924.10
Upgrade
P/OCF Ratio
28.7124.8736.9645.7513.0117.97
Upgrade
EV/Sales Ratio
1.461.731.711.381.782.06
Upgrade
EV/EBITDA Ratio
17.7634.8978.1322.9115.0019.25
Upgrade
EV/EBIT Ratio
---180.5525.7148.01
Upgrade
EV/FCF Ratio
28.9044.10296.41-12.6022.15
Upgrade
Debt / Equity Ratio
0.070.080.100.120.140.18
Upgrade
Debt / EBITDA Ratio
5.761.402.501.601.111.46
Upgrade
Debt / FCF Ratio
2.193.0023.62-1.202.23
Upgrade
Asset Turnover
0.530.590.590.610.650.66
Upgrade
Inventory Turnover
6.537.206.827.037.247.97
Upgrade
Quick Ratio
2.232.602.342.192.632.58
Upgrade
Current Ratio
2.903.272.882.793.033.12
Upgrade
Return on Equity (ROE)
-1.05%3.03%1.91%6.89%9.64%6.41%
Upgrade
Return on Assets (ROA)
-2.86%-0.27%-1.26%0.29%2.80%1.77%
Upgrade
Return on Capital (ROIC)
-3.17%-0.30%-1.43%0.34%3.23%2.05%
Upgrade
Return on Capital Employed (ROCE)
---0.50%5.00%3.30%
Upgrade
Earnings Yield
-1.09%2.14%1.32%5.46%5.47%3.17%
Upgrade
FCF Yield
3.10%2.06%0.31%-2.09%6.90%4.15%
Upgrade
Dividend Yield
0.97%0.76%0.49%2.83%4.43%3.04%
Upgrade
Payout Ratio
-23.18%185.32%99.88%52.24%159.36%
Upgrade
Buyback Yield / Dilution
-0.42%-1.28%0.04%-0.40%0.43%0.34%
Upgrade
Total Shareholder Return
0.55%-0.52%0.53%2.42%4.86%3.37%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.